Walleye Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$649K Sell
7,300
-12,000
-62% -$1.23M ﹤0.01% 2447
2025
Q4
$1.84M Buy
19,300
+13,700
+245% +$1.38M 0.01% 1945
2025
Q3
$552K Sell
5,600
-29,500
-84% -$3.15M ﹤0.01% 2530
2025
Q2
$3.74M Buy
35,100
+27,200
+344% +$2.75M 0.01% 1068
2025
Q1
$719K Sell
7,900
-84,800
-91% -$9.49M ﹤0.01% 2260
2024
Q4
$10.6M Buy
92,700
+2,500
+3% +$285K 0.03% 594
2024
Q3
$10.7M Sell
90,200
-28,400
-24% -$2.61M 0.02% 647
2024
Q2
$9.53M Sell
118,600
-13,100
-10% -$1.2M 0.02% 792
2024
Q1
$12.1M Buy
131,700
+37,700
+40% +$3.61M 0.02% 721
2023
Q4
$9.92M Buy
94,000
+22,700
+32% +$2.29M 0.02% 678
2023
Q3
$7.75M Sell
71,300
-600
-0.8% -$66.4K 0.02% 726
2023
Q2
$7.76M Buy
71,900
+70,400
+4,693% +$7.92M 0.03% 512
2023
Q1
$187K Buy
+1,500
New +$206K ﹤0.01% 2519
2022
Q4
Sell
-4,200
Closed -$566K 3197
2022
Q3
$566K Buy
+4,200
New +$642K 0.01% 1379

Other funds holding BNTX

Walleye Capital's BNTX Position: Q1 2026 in Review

Walleye Capital reduced its BioNTech (BNTX) stake by 48% in Q1 2026, selling an estimated $848K and leaving 9,066 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

Walleye Capital first reported a position in BNTX in Q3 2023 and has held it in 10 quarters since. The position peaked at $6.93M in Q2 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Walleye Capital held 9,066 shares of BioNTech worth $806K as of Q1 2026.
  • Walleye Capital sold 8,253 BioNTech shares in Q1 2026, an estimated $848K.
  • BioNTech made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2274 holding.
  • Walleye Capital first reported a position in BioNTech in Q3 2023 and has held it in 10 quarters since.
  • Walleye Capital's BioNTech position peaked at $6.93M in Q2 2024.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.